高级搜索

2023—2025年绵阳市茶叶农药残留状况及膳食摄入风险评估

2023-2025 Survey on Pesticide Residue and Dietary Intake Risk of Tea Products in Mianyang, Sichuan

  • 摘要:
    目的 了解绵阳市茶叶农药残留情况并评估膳食摄入风险,为监管部门提供科学依据。
    方法 采集2023—2025年绵阳市茶叶样品150份,检测茶叶中23种农药残留,根据GB 2763—2026《食品安全国家标准 食品中农药最大残留限量》判定农药残留量是否超标,并分析评估6种检出农药对人体的慢、急性膳食摄入风险。
    结果 150份测试样本中,检出农药残留样品9份,超标样品1份,检出率6.0%,超标率0.67%,超标农药为吡虫啉。本次共检出6种农药,分别是吡虫啉、毒死蜱、联苯菊酯、啶虫脒、噻嗪酮和灭多威,检出频率最高的是吡虫啉和毒死蜱。对其进行膳食摄入安全性评价,农药残留引起的慢性膳食摄入风险在0.070%~0.514%,急性膳食摄入风险在0.028%~7.704%。
    结论 2023—2025年绵阳市茶叶农药残留检出率较低,各类农药残留引起的膳食摄入风险均在可接受范围内。吡虫啉超标应引起监管部门高度重视。

     

    Abstract:
    Objective Pesticide residue in tea products was surveyed in Mianyang, Sichuan to assess dietary intake risks for regulatory enforcement.
    Method One-hundred-fifty tea specimens were collected randomly from the market at Mianyan City from 2023 to 2025. Residues of 23 pesticides were detected in the sampled products. Whether a pesticide was legally allowed for the application and its concentration in a product was within the permitted limit or not were determined according to the National Food Safety Standard—Maximum Residue Limits for Pesticides in Food (GB 2763—2026). For food safety, the most frequently detected pesticides that are potentially hazardous to health were assessed for risks of chronic and acute health implications.
    Result Of the 150 tea products, 9 were found contaminated with over the limit pesticides, i.e., a 6.0% positive rate, and one contained imidacloprid, i.e., 0.67% of the total. Other than imidacloprid, chlorpyrifos, bifenthrin, acetamiprid, buprofezin, and methomyl were also detected in the specimens, with imidacloprid and chlorpyrifos showing the highest occurrence rates. The risks of consuming teas containing these elements at acceptable daily intakes were estimated to be 0.070-0.514% for chronic ill-effects and 0.028-7.704% for acute ailments.
    Conclusion According to the 2023-2025 survey in Mianyang, the pesticide contamination rate in tea products was generally low with miniscule dietary intake risks. Special regulatory attention might be required on the use and presence of imidacloprid.

     

/

返回文章
返回